©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 6, 2021; 9(28): 8482-8491
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8482
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8482
Postmenopausal women with hyperandrogenemia: Three case reports
Xiao-Dan Zhu, Lin-Yu Zhou, Jian Jiang, Tian-An Jiang, Department of Ultrasound Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang Province, China
Author contributions: Zhu XD drafted the manuscript, collected the data, and reviewed the literature; Zhou LY and Jiang J performed the histological examination and reviewed the manuscript; Jiang TA provided academic help, and critically reviewed the manuscript; All authors have confirmed and approved the final manuscript.
Supported by National Natural Science Foundation of China , No. 81971623, and No. 82027803.
Informed consent statement: Informed written consent was obtained from patients for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist(2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Tian-An Jiang, MD, Chief Physician, Director, Department of Ultrasound Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou 310006, Zhejiang Province, China. tiananjiang@zju.edu.cn
Received: March 12, 2021
Peer-review started: March 12, 2021
First decision: June 24, 2021
Revised: July 5, 2021
Accepted: August 18, 2021
Article in press: August 18, 2021
Published online: October 6, 2021
Processing time: 199 Days and 21.1 Hours
Peer-review started: March 12, 2021
First decision: June 24, 2021
Revised: July 5, 2021
Accepted: August 18, 2021
Article in press: August 18, 2021
Published online: October 6, 2021
Processing time: 199 Days and 21.1 Hours
Core Tip
Core Tip: Ovarian steroid cell tumors are a rare sex cord-stromal tumor accounting for approximately 0.1% of all ovarian tumors. Although virilization caused by increased serum testosterone levels is an important clinical feature of ovarian steroid cell tumors, it is often completely asymptomatic. Therefore, while paying attention to the typical imaging features of ovarian steroid cell tumors, we cannot ignore clinically asymptomatic patients, especially postmenopausal women.